Predictors of Days Unable to Work Among Genotype 1 Treatment-NaiVE Chronic Hepatitis C Patients: Post-Hoc Analyses of Data From Phase 3 Advance and Illuminate Studies

被引：0
|
作者：
Hernandez, Ning C.
Vera-Llonch, Montserrat
Aggarwal, Jyoti
Donepudi, Mrudula
Younossi, Zobair M.
Goss, Thomas F.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S955 / S955
页数：1
相关论文
共 50 条
  • [11] Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
    Vera-Llonch, M.
    Martin, M.
    Aggarwal, J.
    Donepudi, M.
    Bayliss, M.
    Goss, T.
    Younossi, Z.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 124 - 133
  • [12] NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naive Patients with Chronic Hepatitis C
    D'Aliberti, Deborah
    Cacciola, Irene
    Musolino, Cristina
    Raffa, Giuseppina
    Filomia, Roberto
    Alibrandi, Angela
    Benfatto, Salvatore
    Beninati, Concetta
    Saitta, Carlo
    Giosa, Domenico
    Romeo, Orazio
    Raimondo, Giovanni
    Pollicino, Teresa
    INTERVIROLOGY, 2018, 61 (01) : 1 - 8
  • [13] PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS
    Zeuzem, S.
    Demasi, R.
    Foster, G. R.
    Buti, M.
    Baldini, A.
    Luo, D.
    Witek, J.
    Rizzetto, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S452 - S452
  • [14] Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies
    Buti, Maria
    Gros, Blanca
    Oyagueez, Itziar
    Andrade, Raul J.
    Angel Serra, Miguel
    Turnes, Juan
    Casado, Miguel A.
    HEPATOLOGY, 2013, 58 : 1133A - 1133A
  • [15] Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naive Genotype 1b Chronic Hepatitis C Patients
    Abe, Hiroshi
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Kato, Keizo
    Takaguchi, Koichi
    Asano, Toru
    Chuganji, Yoshimichi
    Sakamoto, Choitsu
    Toyoda, Hidenori
    Kumada, Takashi
    Ide, Tatsuya
    Sata, Michio
    Aizawa, Yoshio
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [16] Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naive patients from India
    Behera, Manas Kumar
    Shukla, Sunit Kumar
    Dixit, Vinod Kumar
    Nath, Preetam
    Abhilash, V. B.
    Asati, Pankaj Kumar
    Jain, Ashok Kumar
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (02) : 200 - 206
  • [17] NS3 GENETIC VARIABILITY IN HCV GENOTYPE 1A ISOLATES FROM LIVER TISSUES AND SERUM SAMPLES OF TREATMENT-NAiVE PATIENTS WITH CHRONIC HEPATITIS C
    D'Aliberti, D.
    Cacciola, I.
    Benfatto, S.
    Mannino, F.
    Filomia, R.
    Beninati, C.
    Saitta, C.
    Raimondo, G.
    Pollicino, T.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E35 - E36
  • [18] NS3 GENETIC VARIABILITY IN HCV GENOTYPE 1A ISOLATES FROM LIVER TISSUE AND SERUM SAMPLES OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C
    D'aliberti, D.
    Cacciola, I.
    Benfatto, S.
    Mannino, F.
    Filomia, R.
    Beninati, C.
    Saitta, C.
    Raimondo, G.
    Pollicino, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S403 - S403
  • [19] Open-label phase 2 study of faldaprevir, deleobuvir and ribavirin in Japanese treatment-naive patients with chronic hepatitis C virus genotype 1 infection
    Yatsuhashi, Hiroshi
    Kodani, Nobuyoshi
    Ugai, Hiroyuki
    Omata, Masao
    HEPATOLOGY RESEARCH, 2016, 46 (03) : E189 - E193
  • [20] NS3 genetic variability in HCV genotype-1b isolates from liver specimens and blood samples of treatment-naive patients with chronic hepatitis C
    Maimone, Sergio
    Musolino, Cristina
    Squadrito, Giovanni
    Raffa, Giuseppina
    Pollicino, Teresa
    Raimondo, Giovanni
    ANTIVIRAL THERAPY, 2013, 18 (01) : 131 - 134
12345